Clinical Trial Update: Paradigm I Clinical Trial: Study of the PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemia Attack or Paradoxical Embolism [NA]

View source ↗

Summary

This entry reports a clinical trial called Paradigm I evaluating the PFX Closure System to close a patent foramen ovale in people with cryptogenic stroke or tra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cryptogenic Stroke
• Transient Ischemic Attack

Snippet

Sponsor: Cierra | Conditions: Patent Foramen Ovale | NA | Status: UNKNOWN